The AI boom has led to a growing debate in the therapy and counseling profession: Is the technology a way to save time on ...
LOS ANGELES, CA - July 15, 2026 - PRESSADVANTAGE - Muse Treatment has released a new educational resource that examines ...
14hon MSN
Extremist violence like the Islamic Center shooting can be prevented, experts say. Here’s how.
Almost two months after two teenagers shot and killed three people at the Islamic Center of San Diego in Clairemont, a key ...
Despite multiple complaints — and videos — of physical abuse and mistreatment of students, Arkansas' Delta Institute continues to receive public funds. It is just one of hundreds of private schools ...
Small-cap healthcare and emerging growth stocks continue to generate investor interest as multiple companies announced ...
Kiniksa Pharmaceuticals is anchored by Arcalyst, the only FDA-approved therapy for recurrent pericarditis, driving robust ...
First patients dosed in OPTIMAL-e[1] Phase 2 study evaluating TLX597-Tx for metastatic hormone-sensitive prostate cancer at St Vincent's Hospital Sydney. OPTIMAL-e will evaluate TLX597-Tx in earlier ...
First-of-its-kind facility in Australia where radiopharmaceuticals are developed, manufactured and administered to patients ...
The views and opinions expressed in our letters section are those of the authors and do not necessarily reflect the official ...
Celcuity wins FDA approval for REVTORPYK in HR+/HER2- breast cancer; outlook tempered by phase 3 data, competition & launch ...
The early-stage trial of a potential novel nonartemisinin malaria drug found it rapidly killed malaria parasites and was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results